I believe that the language used by IMU in recent announcements surrounding the immune response to treatment is geared toward the Accelerated Approval process, as key data such as this fits nicely with the AA requirements, not necessarily looking at endpoints for acknowledgement that there are signs the drug is showing consistent positive signs that point to the potential for meeting endpoints.
DYOR opinion only
I believe that the language used by IMU in recent announcements...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.5¢ | 5.3¢ | $817.0K | 15.17M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 4719788 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 453183 | 5 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |